CYP2D6 genetic variation in Ugandans

Jun Miura^{1

2}, Celestino Obua³, Catherine Abbo⁴, Tomonori Tateishi⁵, Sunao Kaneko⁶

Affiliations

¹ Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. junmiura0815@med.showa-u.ac.jp.
² Department of Clinical Pharmacology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. junmiura0815@med.showa-u.ac.jp.
³ Department of Pharmacology and Therapeutics, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
⁴ Department of Psychiatry, College of Health Sciences, Makerere University, Kampala, Uganda.
⁵ Department of Clinical Pharmacology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
⁶ Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Jun Miura et al. Eur J Clin Pharmacol. 2022 Jan.

. 2022 Jan;78(1):155-157.

doi: 10.1007/s00228-021-03208-8. Epub 2021 Aug 27.

Jun Miura^{1

2}, Celestino Obua³, Catherine Abbo⁴, Tomonori Tateishi⁵, Sunao Kaneko⁶

¹ Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. junmiura0815@med.showa-u.ac.jp.
² Department of Clinical Pharmacology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. junmiura0815@med.showa-u.ac.jp.
³ Department of Pharmacology and Therapeutics, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
⁴ Department of Psychiatry, College of Health Sciences, Makerere University, Kampala, Uganda.
⁵ Department of Clinical Pharmacology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
⁶ Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

No abstract available

Keywords: Africa; Cytochrome P450 2D6 (CYP2D6); Genetic variation; Poor metaboliser; Uganda; Ultrarapid metaboliser.

References

1. Jarvis JP, Peter AP, Shaman JA (2019) Consequences of CYP2D6 copy-number variation for pharmacogenomics in psychiatry. Front Psychiatry 10:432. https://doi.org/10.3389/fpsyt.2019.00432 - DOI - PubMed - PMC
1. Taylor C, Crosby I, Yip V, Maguire P, Pirmohamed M, Turner RM (2020) A Review of the important role of CYP2D6 in pharmacogenomics. Genes (Basel) 11(11). https://doi.org/10.3390/genes11111295
1. Nofziger C, Turner AJ, Sangkuhl K, Whirl-Carrillo M, Agundez JAG, Black JL, Dunnenberger HM, Ruano G, Kennedy MA, Phillips MS, Hachad H, Klein TE, Gaedigk A (2020) PharmVar GeneFocus: CYP2D6. Clin Pharmacol Ther 107(1):154–170. https://doi.org/10.1002/cpt.1643 - DOI - PubMed
1. Gene-specific Information Tables for CYP2D6. https://www.pharmgkb.org/page/cyp2d6RefMaterials
1. Dorado P, Caceres MC, Pozo-Guisado E, Wong ML, Licinio J, Llerena A (2005) Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use. Biotechniques 39(4):571–574 - DOI